2007
DOI: 10.1016/j.mrgentox.2006.11.008
|View full text |Cite
|
Sign up to set email alerts
|

How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
201
0
2

Year Published

2008
2008
2021
2021

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 398 publications
(206 citation statements)
references
References 34 publications
3
201
0
2
Order By: Relevance
“…Thus, with this system in place, three genotoxicants and three presumed non-genotoxicants were characterized correctly. Collectively, these results support the concept that guidelines regarding cytotoxicity limits, as well as the methods used to accomplish these measurements, should be reconsidered [19,22]. It seems likely that the implementation of such improvements could increase the meaningfulness of mammalian cellbased genotoxicity data.…”
Section: Discussionmentioning
confidence: 53%
See 2 more Smart Citations
“…Thus, with this system in place, three genotoxicants and three presumed non-genotoxicants were characterized correctly. Collectively, these results support the concept that guidelines regarding cytotoxicity limits, as well as the methods used to accomplish these measurements, should be reconsidered [19,22]. It seems likely that the implementation of such improvements could increase the meaningfulness of mammalian cellbased genotoxicity data.…”
Section: Discussionmentioning
confidence: 53%
“…The poor assay specificity of mammalian cell genotoxicity tests has become increasingly well documented [18][19]. One of the chief reasons cited for the high rate of false positive results is the confounding effects of overtly cytotoxic concentrations [18][19][20][21].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…CYP2C6 and CYP2C11 have been shown to be the major enzymes responsible for the bioactivation of CP in uninduced male rat liver microsomes (25), and nitro group-containing aromatic compounds (AF-2 and 4NQO) are reported to be activated by bacterial nitroreductase enzymes (26)(27)(28). It is important that each promutagen is not merely activated by a single speciˆc metabolizing enzyme, but also activated or detoxiˆed by some other metabolizing enzymes, including enzymes of the CYP subfamily, and that the magnitude of the mutagenicity is determined by the metabolic balance between the activation and detoxiˆcation of promutagens (12,13,(18)(19)(20). These lines of evidence and knowledge suggest that the inhibitory eŠect of DMSO on the mutagenicity observed in this study may be attributable to its inhibitory eŠect on the exogenous or endogenous drug-metabolizing enzymes involved in the parallel or sequential metabolic activation/detoxiˆca-tion pathways.…”
Section: Resultsmentioning
confidence: 99%
“…On the other hand some studies have demonstrated that DMSO inhibits several kinds of CYP enzymes involved in the metabolic activation or detoxiˆca-tion of chemical mutagens, even at concentrations of 1 z or less (7)(8)(9)(10)(11). Although the issue of poisoning of enzymes by organic vehicles, including DMSO, in genotoxicity tests has been debated (12,13), data on the eŠect of DMSO on the mutagenicity of promutagens that require metabolic activation are still limited in terms of the number of compounds tested, the kinds of chemical classes studied, and comparative data for mutagenicity obtained at low and high concentrations (14z) of DMSO (5,7,(14)(15)(16)(17). Therefore, in the present study, we examined the mutagenicity of 14 promutagens belonging to several chemical classes and a direct mutagen (as a reference compound) in the presence of DMSO at concentrations of 1z and 14z in the Ames preincubation test, and compared the results, to clarify how much the results are aŠected by DMSO.…”
Section: Introductionmentioning
confidence: 99%